AAPL   327.87 (+1.72%)
MSFT   185.57 (+1.45%)
FB   229.84 (+1.57%)
GOOGL   1,429.46 (+1.07%)
AMZN   2,467.62 (+0.29%)
NVDA   353.39 (+0.78%)
CGC   16.94 (+1.86%)
BABA   219.71 (+0.77%)
MU   53.74 (+4.92%)
TSLA   875.18 (+1.25%)
AMD   52.40 (-0.44%)
T   32.87 (+3.37%)
ACB   13.93 (-2.11%)
F   7.29 (+10.96%)
GILD   77.10 (-0.57%)
DIS   126.76 (+2.48%)
NFLX   414.38 (+0.01%)
BAC   28.42 (+6.12%)
BA   214.19 (+16.22%)
AAPL   327.87 (+1.72%)
MSFT   185.57 (+1.45%)
FB   229.84 (+1.57%)
GOOGL   1,429.46 (+1.07%)
AMZN   2,467.62 (+0.29%)
NVDA   353.39 (+0.78%)
CGC   16.94 (+1.86%)
BABA   219.71 (+0.77%)
MU   53.74 (+4.92%)
TSLA   875.18 (+1.25%)
AMD   52.40 (-0.44%)
T   32.87 (+3.37%)
ACB   13.93 (-2.11%)
F   7.29 (+10.96%)
GILD   77.10 (-0.57%)
DIS   126.76 (+2.48%)
NFLX   414.38 (+0.01%)
BAC   28.42 (+6.12%)
BA   214.19 (+16.22%)
AAPL   327.87 (+1.72%)
MSFT   185.57 (+1.45%)
FB   229.84 (+1.57%)
GOOGL   1,429.46 (+1.07%)
AMZN   2,467.62 (+0.29%)
NVDA   353.39 (+0.78%)
CGC   16.94 (+1.86%)
BABA   219.71 (+0.77%)
MU   53.74 (+4.92%)
TSLA   875.18 (+1.25%)
AMD   52.40 (-0.44%)
T   32.87 (+3.37%)
ACB   13.93 (-2.11%)
F   7.29 (+10.96%)
GILD   77.10 (-0.57%)
DIS   126.76 (+2.48%)
NFLX   414.38 (+0.01%)
BAC   28.42 (+6.12%)
BA   214.19 (+16.22%)
AAPL   327.87 (+1.72%)
MSFT   185.57 (+1.45%)
FB   229.84 (+1.57%)
GOOGL   1,429.46 (+1.07%)
AMZN   2,467.62 (+0.29%)
NVDA   353.39 (+0.78%)
CGC   16.94 (+1.86%)
BABA   219.71 (+0.77%)
MU   53.74 (+4.92%)
TSLA   875.18 (+1.25%)
AMD   52.40 (-0.44%)
T   32.87 (+3.37%)
ACB   13.93 (-2.11%)
F   7.29 (+10.96%)
GILD   77.10 (-0.57%)
DIS   126.76 (+2.48%)
NFLX   414.38 (+0.01%)
BAC   28.42 (+6.12%)
BA   214.19 (+16.22%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Novozymes A/SAbattis BioceuticalsABcann GlobalABZENA/PAR VTG FPD 0.002Admedus
SymbolOTCMKTS:NVZMFOTCMKTS:ATTBFCVE:ABCNLON:ABZAASX:AHZ
Price Information
Current Price$57.13$0.02N/AN/AN/A
52 Week RangeN/AN/AN/AN/AN/A
Beat the Market™ Rank
Overall Score0.40.40.60.60.5
Analysis Score0.00.00.00.00.0
Community Score2.01.92.82.92.5
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.00.00.00.0
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/AN/A
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market CapN/AN/AN/AN/AN/A
BetaN/AN/AN/AN/AN/A
Average Volume2,475598,5391,514,73326,706N/A
Sales & Book Value
Annual RevenueN/AN/AN/AN/A$17.08 million
Price / SalesN/AN/AN/AN/A0.00
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book ValueN/AN/AN/AN/AA$2.63 per share
Price / BookN/AN/AN/AN/A0.00
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSN/AN/AN/AN/AA($0.99)
Trailing P/E Ratio0.000.000.000.000.00
Forward P/E Ratio∞∞N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/A16.85%
Current RatioN/AN/AN/AN/A2.82%
Quick RatioN/AN/AN/AN/A2.57%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees6,131N/AN/AN/AN/A
Shares OutstandingN/AN/AN/AN/A5.91 million
Next Earnings DateN/AN/AN/AN/AN/A
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.